v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
OPERATING EXPENSES:        
Research and development $ 24,729 $ 17,882 $ 47,618 $ 33,201
General and administrative 6,561 3,895 11,581 7,292
Total operating expenses 31,290 21,777 59,199 40,493
LOSS FROM OPERATIONS (31,290) (21,777) (59,199) (40,493)
OTHER INCOME (EXPENSE):        
Interest income 2,696 1,627 3,821 2,875
Interest expense (272) 0 (370) 0
Other income (expense) (69) (41) (56) (76)
Total other income 2,355 1,586 3,395 2,799
Net loss (28,935) (20,191) (55,804) (37,694)
OTHER COMPREHENSIVE LOSS:        
Unrealized gains (losses) on marketable securities (107) (34) (229) (122)
Total other comprehensive loss (107) (34) (229) (122)
TOTAL COMPREHENSIVE LOSS $ (29,042) $ (20,225) $ (56,033) $ (37,816)
Net loss per share of common stock, basic $ (0.98) $ (17.63) $ (3.6) $ (52.83)
Net loss per share of common stock, diluted $ (0.98) $ (17.63) $ (3.6) $ (52.83)
Weighted-average number of common stock used in net loss per share, basic 29,650,660 1,145,309 15,519,187 713,450
Weighted-average number of common stock used in net loss per share, diluted 29,650,660 1,145,309 15,519,187 713,450